Complete genome sequences of two enterococcus faecalis bacteriophages, EFGrKN and EFGrNG, targeted to phage therapy

Sivan Alkalay-Oren; Naama Gold; Leron Khalifa; Ortal Yerushalmy; Shunit Coppenhagen-Glazer; Ran Nir-Paz; Ronen Hazan

doi:10.1128/MRA.00126-21

Complete genome sequences of two enterococcus faecalis bacteriophages, EFGrKN and EFGrNG, targeted to phage therapy

Sivan Alkalay-Oren, Naama Gold, Leron Khalifa, Ortal Yerushalmy, Shunit Coppenhagen-Glazer, Ran Nir-Paz, Ronen Hazan^*

^*Corresponding author for this work

Institute of Biomedical Research at the Faculty of Dental Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

EFGrKN and EFGrNG are new Enterococcus faecalis phages that were isolated from sewage samples as part of the Israeli Phage Bank (IPB). The complete genomes were sequenced, analyzed, and deposited in GenBank. According to their lytic activity in vitro, it seems that these phages have a potential to be used in future phage therapy treatments.

Original language	American English
Article number	e00126-21
Journal	Microbiology Resource Announcements
Volume	10
Issue number	16
DOIs	https://doi.org/10.1128/MRA.00126-21
State	Published - 22 Apr 2021

Bibliographical note

Funding Information:
The study was funded by the “United States-Israel Binational Science Foundation (BSF)” grant 2017123, the Israel Science Foundation (ISF-IPMP) grant ISF_1349/2020, and the Rosetrees Trust grant A2232.

Publisher Copyright:
© 2021 Alkalay-Oren et al.

Access to Document

10.1128/MRA.00126-21

Cite this

@article{328dca849232495ba1f48b8fc4a83d6c,

title = "Complete genome sequences of two enterococcus faecalis bacteriophages, EFGrKN and EFGrNG, targeted to phage therapy",

abstract = "EFGrKN and EFGrNG are new Enterococcus faecalis phages that were isolated from sewage samples as part of the Israeli Phage Bank (IPB). The complete genomes were sequenced, analyzed, and deposited in GenBank. According to their lytic activity in vitro, it seems that these phages have a potential to be used in future phage therapy treatments.",

author = "Sivan Alkalay-Oren and Naama Gold and Leron Khalifa and Ortal Yerushalmy and Shunit Coppenhagen-Glazer and Ran Nir-Paz and Ronen Hazan",

note = "Funding Information: The study was funded by the “United States-Israel Binational Science Foundation (BSF)” grant 2017123, the Israel Science Foundation (ISF-IPMP) grant ISF_1349/2020, and the Rosetrees Trust grant A2232. Publisher Copyright: {\textcopyright} 2021 Alkalay-Oren et al.",

year = "2021",

month = apr,

day = "22",

doi = "10.1128/MRA.00126-21",

language = "American English",

volume = "10",

journal = "Microbiology Resource Announcements",

issn = "2169-8287",

publisher = "American Society for Microbiology",

number = "16",

}

TY - JOUR

T1 - Complete genome sequences of two enterococcus faecalis bacteriophages, EFGrKN and EFGrNG, targeted to phage therapy

AU - Alkalay-Oren, Sivan

AU - Gold, Naama

AU - Khalifa, Leron

AU - Yerushalmy, Ortal

AU - Coppenhagen-Glazer, Shunit

AU - Nir-Paz, Ran

AU - Hazan, Ronen

N1 - Funding Information: The study was funded by the “United States-Israel Binational Science Foundation (BSF)” grant 2017123, the Israel Science Foundation (ISF-IPMP) grant ISF_1349/2020, and the Rosetrees Trust grant A2232. Publisher Copyright: © 2021 Alkalay-Oren et al.

PY - 2021/4/22

Y1 - 2021/4/22

N2 - EFGrKN and EFGrNG are new Enterococcus faecalis phages that were isolated from sewage samples as part of the Israeli Phage Bank (IPB). The complete genomes were sequenced, analyzed, and deposited in GenBank. According to their lytic activity in vitro, it seems that these phages have a potential to be used in future phage therapy treatments.

AB - EFGrKN and EFGrNG are new Enterococcus faecalis phages that were isolated from sewage samples as part of the Israeli Phage Bank (IPB). The complete genomes were sequenced, analyzed, and deposited in GenBank. According to their lytic activity in vitro, it seems that these phages have a potential to be used in future phage therapy treatments.

UR - http://www.scopus.com/inward/record.url?scp=85104674119&partnerID=8YFLogxK

U2 - 10.1128/MRA.00126-21

DO - 10.1128/MRA.00126-21

M3 - Article

C2 - 33888497

AN - SCOPUS:85104674119

SN - 2169-8287

VL - 10

JO - Microbiology Resource Announcements

JF - Microbiology Resource Announcements

IS - 16

M1 - e00126-21

ER -

Complete genome sequences of two enterococcus faecalis bacteriophages, EFGrKN and EFGrNG, targeted to phage therapy

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this